81/100B547.03
USD
4.03
(0.74%)
Pre Open·549.72USD+2.69(+0.49%)
Last updated: · Delayed 15 min
Vertex Pharmaceuticals price to sales (P/S) ratioWhat is the P/S ratio? The price-to-sales ratio compares a company's market value with its revenue over the last year: what you pay for each dollar of sales.
Vertex Pharmaceuticals's P/S ratio is 10.67: its market cap of 138.65B USD over revenue of 12.99B USD in the last twelve months.
- Today
- 10.67
- Average, 5 years
- 10.40
- Low, 5 years
- 6.57
- High, 5 years
- 12.82
P/S ratio = market cap ÷ revenue (last 12 months) = 138.65B ÷ 12.99B = 10.67
Each day's market cap over the revenue of the last four quarters reported by that day.
P/S ratio by year and by quarter
| Fiscal year | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Today | 10.67 | 138.65B | 12.99B | |
| FY2025 | 31 Dec 2025 | 9.60 | 115.92B | 12.07B |
| FY2024 | 31 Dec 2024 | 9.41 | 103.70B | 11.02B |
| FY2023 | 31 Dec 2023 | 10.62 | 104.86B | 9.87B |
| FY2022 | 31 Dec 2022 | 8.28 | 73.96B | 8.93B |
| FY2021 | 31 Dec 2021 | 7.47 | 56.59B | 7.57B |
| FY2020 | 31 Dec 2020 | 9.90 | 61.41B | 6.21B |
| FY2019 | 31 Dec 2019 | 13.50 | 56.21B | 4.16B |
| FY2018 | 31 Dec 2018 | 13.83 | 42.14B | 3.05B |
| FY2017 | 31 Dec 2017 | 14.99 | 37.29B | 2.49B |
| FY2016 | 31 Dec 2016 | 10.54 | 17.95B | 1.70B |
| FY2015 | 31 Dec 2015 | 29.36 | 30.30B | 1.03B |
| FY2014 | 31 Dec 2014 | 48.08 | 27.91B | 580.42M |
| FY2013 | 31 Dec 2013 | 13.78 | 16.70B | 1.21B |
| FY2012 | 31 Dec 2012 | 5.82 | 8.88B | 1.53B |
| FY2011 | 31 Dec 2011 | 4.82 | 6.80B | 1.41B |
| FY2010 | 31 Dec 2010 | 48.96 | 7.02B | 143.37M |
| FY2009 | 31 Dec 2009 | 72.75 | 7.42B | 102.05M |
| FY2008 | 31 Dec 2008 | 24.33 | 4.27B | 175.50M |
| FY2007 | 31 Dec 2007 | 15.06 | 3.00B | 199.01M |
| FY2006 | 31 Dec 2006 | 19.58 | 4.24B | 216.36M |
| FY2005 | 31 Dec 2005 | 15.35 | 2.47B | 160.89M |
| FY2004 | 31 Dec 2004 | 8.09 | 830.50M | 102.72M |
| FY2003 | 31 Dec 2003 | 11.53 | 796.99M | 69.14M |
| FY2002 | 31 Dec 2002 | 7.45 | 1.20B | 161.09M |
| FY2001 | 31 Dec 2001 | 10.93 | 1.83B | 167.49M |
| FY2000 | 31 Dec 2000 | 61.94 | 4.84B | 78.13M |
| FY1999 | 31 Dec 1999 | 14.50 | 893.13M | 61.60M |
| FY1998 | 31 Dec 1998 | 16.95 | 752.65M | 44.40M |
| FY1997 | 31 Dec 1997 | 18.28 | 800.71M | 43.80M |
| FY1996 | 31 Dec 1996 | 56.57 | 752.34M | 13.30M |
| FY1995 | 31 Dec 1995 | 20.46 | 452.18M | 22.10M |
| FY1994 | 31 Dec 1994 | 12.03 | 235.71M | 19.60M |
| FY1993 | 31 Dec 1993 | 8.29 | 231.25M | 27.90M |
| FY1992 | 31 Dec 1992 | 31.16 | 118.39M | 3.80M |
| FY1991 | 31 Dec 1991 | 33.68 | 107.79M | 3.20M |
| FY1990 | 31 Dec 1990 | 38.50 | 88.54M | 2.30M |
| Quarter | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 10.20 | 132.53B | 12.99B |
| Q2 FY2026 | 30 Jun 2026 | 9.99 | 126.12B | 12.62B |
| Q1 FY2026 | 31 Mar 2026 | 9.26 | 113.47B | 12.26B |
| Q4 FY2025 | 31 Dec 2025 | 9.56 | 115.11B | 12.04B |
| Q3 FY2025 | 30 Sept 2025 | 8.54 | 100.10B | 11.72B |
| Q2 FY2025 | 30 Jun 2025 | 10.01 | 114.28B | 11.42B |
| Q1 FY2025 | 31 Mar 2025 | 11.22 | 124.55B | 11.10B |
| Q4 FY2024 | 31 Dec 2024 | 9.41 | 103.70B | 11.02B |
| Q3 FY2024 | 30 Sept 2024 | 11.30 | 119.99B | 10.62B |
| Q2 FY2024 | 30 Jun 2024 | 11.77 | 121.63B | 10.33B |
| Q1 FY2024 | 31 Mar 2024 | 10.66 | 108.57B | 10.18B |
| Q4 FY2023 | 31 Dec 2023 | 10.62 | 104.86B | 9.87B |
| Q3 FY2023 | 30 Sept 2023 | 9.29 | 89.72B | 9.65B |
| Q2 FY2023 | 30 Jun 2023 | 9.54 | 90.69B | 9.51B |
| Q1 FY2023 | 31 Mar 2023 | 8.81 | 81.10B | 9.21B |
| Q4 FY2022 | 31 Dec 2022 | 8.31 | 74.19B | 8.93B |
| Q3 FY2022 | 30 Sept 2022 | 8.54 | 74.27B | 8.70B |
| Q2 FY2022 | 30 Jun 2022 | 8.64 | 72.11B | 8.35B |
| Q1 FY2022 | 31 Mar 2022 | 8.38 | 66.57B | 7.95B |
| Q4 FY2021 | 31 Dec 2021 | 7.38 | 55.91B | 7.57B |
| Q3 FY2021 | 30 Sept 2021 | 6.56 | 46.78B | 7.13B |
| Q2 FY2021 | 30 Jun 2021 | 7.81 | 52.22B | 6.68B |
| Q1 FY2021 | 31 Mar 2021 | 8.69 | 55.74B | 6.41B |
| Q4 FY2020 | 31 Dec 2020 | 9.90 | 61.46B | 6.21B |
| Q3 FY2020 | 30 Sept 2020 | 11.83 | 70.86B | 5.99B |
| Q2 FY2020 | 30 Jun 2020 | 13.95 | 75.38B | 5.40B |
| Q1 FY2020 | 31 Mar 2020 | 12.83 | 61.82B | 4.82B |
| Q4 FY2019 | 31 Dec 2019 | 13.57 | 56.49B | 4.16B |
| Q3 FY2019 | 30 Sept 2019 | 12.03 | 43.53B | 3.62B |
| Q2 FY2019 | 30 Jun 2019 | 13.48 | 46.58B | 3.45B |
| Q1 FY2019 | 31 Mar 2019 | 14.57 | 47.57B | 3.27B |
| Q4 FY2018 | 31 Dec 2018 | 13.86 | 42.23B | 3.05B |
| Q3 FY2018 | 30 Sept 2018 | 17.26 | 48.83B | 2.83B |
| Q2 FY2018 | 30 Jun 2018 | 16.47 | 43.19B | 2.62B |
| Q1 FY2018 | 31 Mar 2018 | 17.09 | 41.27B | 2.41B |
| Q4 FY2017 | 31 Dec 2017 | 15.15 | 37.70B | 2.49B |
| Q3 FY2017 | 30 Sept 2017 | 16.57 | 38.05B | 2.30B |
| Q2 FY2017 | 30 Jun 2017 | 14.97 | 31.90B | 2.13B |
| Q1 FY2017 | 31 Mar 2017 | 13.33 | 26.90B | 2.02B |
| Q4 FY2016 | 31 Dec 2016 | 10.62 | 18.08B | 1.70B |
| Q3 FY2016 | 30 Sept 2016 | 12.74 | 21.17B | 1.66B |
| Q2 FY2016 | 30 Jun 2016 | 13.50 | 21.03B | 1.56B |
| Q1 FY2016 | 31 Mar 2016 | 15.00 | 19.38B | 1.29B |
| Q4 FY2015 | 31 Dec 2015 | 29.19 | 30.13B | 1.03B |
| Q3 FY2015 | 30 Sept 2015 | 33.20 | 25.20B | 758.96M |
| Q2 FY2015 | 30 Jun 2015 | 47.33 | 29.73B | 628.13M |
| Q1 FY2015 | 31 Mar 2015 | 47.01 | 28.23B | 600.47M |
| Q4 FY2014 | 31 Dec 2014 | 48.68 | 28.26B | 580.42M |
| Q3 FY2014 | 30 Sept 2014 | 33.69 | 26.52B | 787.02M |
| Q2 FY2014 | 30 Jun 2014 | 26.68 | 22.14B | 829.73M |
| Q1 FY2014 | 31 Mar 2014 | 16.38 | 16.41B | 1.00B |
| Q4 FY2013 | 31 Dec 2013 | 14.18 | 17.18B | 1.21B |
| Q3 FY2013 | 30 Sept 2013 | 14.54 | 17.37B | 1.19B |
| Q2 FY2013 | 30 Jun 2013 | 13.51 | 17.68B | 1.31B |
| Q1 FY2013 | 31 Mar 2013 | 8.21 | 11.63B | 1.42B |
| Q4 FY2012 | 31 Dec 2012 | 5.89 | 8.99B | 1.53B |
| Q3 FY2012 | 30 Sept 2012 | 6.85 | 12.03B | 1.76B |
| Q2 FY2012 | 30 Jun 2012 | 5.68 | 11.82B | 2.08B |
| Q1 FY2012 | 31 Mar 2012 | 4.80 | 8.53B | 1.78B |
| Q4 FY2011 | 31 Dec 2011 | 4.90 | 6.91B | 1.41B |
| Q3 FY2011 | 30 Sept 2011 | 10.03 | 9.16B | 912.81M |
| Q2 FY2011 | 30 Jun 2011 | 38.31 | 10.63B | 277.41M |
| Q1 FY2011 | 31 Mar 2011 | 49.83 | 9.70B | 194.60M |
| Q4 FY2010 | 31 Dec 2010 | 49.20 | 7.05B | 143.37M |
| Q3 FY2010 | 30 Sept 2010 | 62.15 | 6.94B | 111.74M |
| Q2 FY2010 | 30 Jun 2010 | 58.40 | 6.59B | 112.90M |
| Q1 FY2010 | 31 Mar 2010 | 81.03 | 8.13B | 100.34M |
| Q4 FY2009 | 31 Dec 2009 | 83.66 | 8.52B | 101.89M |
| Q3 FY2009 | 30 Sept 2009 | 67.20 | 6.77B | 100.81M |
| Q2 FY2009 | 30 Jun 2009 | 57.76 | 6.21B | 107.46M |
| Q1 FY2009 | 31 Mar 2009 | 28.38 | 4.48B | 157.81M |
| Q4 FY2008 | 31 Dec 2008 | 25.77 | 4.52B | 175.50M |
| Q3 FY2008 | 30 Sept 2008 | 24.05 | 4.66B | 193.69M |
| Q2 FY2008 | 30 Jun 2008 | 22.86 | 4.64B | 203.09M |
| Q1 FY2008 | 31 Mar 2008 | 18.69 | 3.21B | 171.88M |
| Q4 FY2007 | 31 Dec 2007 | 15.27 | 3.04B | 199.01M |
| Q3 FY2007 | 30 Sept 2007 | 20.92 | 5.07B | 242.27M |
| Q2 FY2007 | 30 Jun 2007 | 14.50 | 3.69B | 254.55M |
| Q1 FY2007 | 31 Mar 2007 | 14.33 | 3.53B | 246.08M |
| Q4 FY2006 | 31 Dec 2006 | 21.46 | 4.64B | 216.36M |
| Q3 FY2006 | 30 Sept 2006 | 20.42 | 3.80B | 185.86M |
| Q2 FY2006 | 30 Jun 2006 | 23.60 | 3.98B | 168.78M |
| Q1 FY2006 | 31 Mar 2006 | 22.94 | 3.93B | 171.37M |
| Q4 FY2005 | 31 Dec 2005 | 18.48 | 2.97B | 160.89M |
| Q3 FY2005 | 30 Sept 2005 | 15.43 | 2.11B | 136.97M |
| Q2 FY2005 | 30 Jun 2005 | 10.87 | 1.39B | 127.59M |
| Q1 FY2005 | 31 Mar 2005 | 6.53 | 743.45M | 113.81M |
| Q4 FY2004 | 31 Dec 2004 | 8.14 | 835.82M | 102.72M |
| Q3 FY2004 | 30 Sept 2004 | 11.25 | 826.79M | 73.49M |
| Q2 FY2004 | 30 Jun 2004 | 13.14 | 854.27M | 65.01M |
| Q1 FY2004 | 31 Mar 2004 | 11.49 | 735.65M | 64.05M |
| Q4 FY2003 | 31 Dec 2003 | 11.64 | 804.88M | 69.14M |
| Q3 FY2003 | 30 Sept 2003 | 9.26 | 947.92M | 102.32M |
| Q2 FY2003 | 30 Jun 2003 | 9.50 | 1.12B | 118.25M |
| Q1 FY2003 | 31 Mar 2003 | 5.95 | 851.22M | 143.00M |
| Q4 FY2002 | 31 Dec 2002 | 7.50 | 1.21B | 161.09M |
| Q3 FY2002 | 30 Sept 2002 | 8.32 | 1.40B | 168.83M |
| Q2 FY2002 | 30 Jun 2002 | 6.65 | 1.16B | 174.92M |
| Q1 FY2002 | 31 Mar 2002 | 13.86 | 2.13B | 154.03M |
| Q4 FY2001 | 31 Dec 2001 | 13.91 | 1.84B | 132.39M |
| Q3 FY2001 | 30 Sept 2001 | 12.66 | 1.27B | 100.57M |
| Q2 FY2001 | 30 Jun 2001 | 40.32 | 2.99B | 74.07M |
| Q1 FY2001 | 31 Mar 2001 | 24.51 | 2.20B | 89.66M |
| Q4 FY2000 | 31 Dec 2000 | 54.56 | 4.26B | 78.13M |
| Q3 FY2000 | 30 Sept 2000 | 51.69 | 4.55B | 88.02M |
| Q2 FY2000 | 30 Jun 2000 | 33.11 | 2.77B | 83.76M |
| Q1 FY2000 | 31 Mar 2000 | 19.60 | 1.22B | 62.02M |
| Q4 FY1999 | 31 Dec 1999 | 15.45 | 903.77M | 58.50M |
| Q3 FY1999 | 30 Sept 1999 | 19.54 | 793.20M | 40.60M |
| Q2 FY1999 | 30 Jun 1999 | 12.44 | 614.71M | 49.40M |
| Q1 FY1999 | 31 Mar 1999 | 15.37 | 634.86M | 41.30M |
| Q4 FY1998 | 31 Dec 1998 | 18.47 | 748.00M | 40.50M |
| Q3 FY1998 | 30 Sept 1998 | 13.23 | 529.00M | 40.00M |
| Q2 FY1998 | 30 Jun 1998 | 15.71 | 551.25M | 35.10M |
| Q1 FY1998 | 31 Mar 1998 | 19.68 | 789.04M | 40.10M |
| Q4 FY1997 | 31 Dec 1997 | 18.61 | 815.29M | 43.80M |
| Q3 FY1997 | 30 Sept 1997 | 24.81 | 928.02M | 37.40M |
| Q2 FY1997 | 30 Jun 1997 | 33.30 | 892.50M | 26.80M |
| Q1 FY1997 | 31 Mar 1997 | 51.04 | 903.46M | 17.70M |
| Q4 FY1996 | 31 Dec 1996 | 67.51 | 897.88M | 13.30M |
| Q3 FY1996 | 30 Sept 1996 | 32.73 | 546.62M | 16.70M |
| Q2 FY1996 | 30 Jun 1996 | 35.71 | 574.92M | 16.10M |
| Q1 FY1996 | 31 Mar 1996 | 22.73 | 443.18M | 19.50M |
| Q4 FY1995 | 31 Dec 1995 | 19.79 | 437.36M | 22.10M |
| Q3 FY1995 | 30 Sept 1995 | 19.48 | 323.44M | 16.60M |
| Q2 FY1995 | 30 Jun 1995 | 13.63 | 283.41M | 20.80M |
| Q1 FY1995 | 31 Mar 1995 | 11.86 | 226.61M | 19.10M |
| Q4 FY1994 | 31 Dec 1994 | 12.55 | 245.91M | 19.60M |
| Q3 FY1994 | 30 Sept 1994 | 6.64 | 231.56M | 34.90M |
| Q2 FY1994 | 30 Jun 1994 | 5.71 | 187.15M | 32.80M |
| Q1 FY1994 | 31 Mar 1994 | 5.97 | 194.55M | 32.60M |
| Q4 FY1993 | 31 Dec 1993 | 9.35 | 260.98M | 27.90M |
| Q3 FY1993 | 30 Sept 1993 | 14.36 | 156.48M | 10.90M |
| Q2 FY1993 | 30 Jun 1993 | 16.89 | 126.67M | 7.50M |
| Q1 FY1993 | 31 Mar 1993 | 24.18 | 94.29M | 3.90M |
| Q4 FY1992 | 31 Dec 1992 | 29.46 | 114.91M | 3.90M |
| Q3 FY1992 | 30 Sept 1992 | 35.10 | 129.86M | 3.70M |
| Q2 FY1992 | 30 Jun 1992 | 25.45 | 89.06M | 3.50M |
| Q1 FY1992 | 31 Mar 1992 | 40.69 | 134.29M | 3.30M |
| Q4 FY1991 | 31 Dec 1991 | 52.68 | 168.57M | 3.20M |
| Q3 FY1991 | 30 Sept 1991 | 42.14 | 126.43M | 3.00M |
| Q2 FY1991 | 30 Jun 1991 | 31.62 | 88.54M | 2.80M |
| Q1 FY1991 | 31 Mar 1991 | 34.05 | 88.54M | 2.60M |
| Q4 FY1990 | 31 Dec 1990 | 38.50 | 88.54M | 2.30M |
| Q3 FY1990 | 30 Sept 1990 | — | 88.54M | — |
| Q2 FY1990 | 30 Jun 1990 | — | 88.54M | — |
| Q1 FY1990 | 31 Mar 1990 | — | 88.54M | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,ROE (return on equity),Debt to equity,Current ratio,All ratios
Common questions about Vertex Pharmaceuticals's P/S ratio
Source: Financial Modeling Prep